Riskpilot← Back to searchSign inGet full accessSpeciallæge Danny Svane ApS
APSActiveCVR 34074283Christiansgade 108Medical specialists activities · NACE 8622Est. 2011— employees
Revenue 2025
DKK -17K
-27% vs 2024
EBITDA margin
100.0%
+27% vs 2024
Equity ratio
58.2%
Financial strength
Net profit 2025
DKK 1,7M
+2456% vs 2024
| Revenue | DKK -17K | -27% |
| EBITDA | DKK -17K | +27% |
| Net profit | DKK 1,7M | +2456% |
| Total assets | DKK 7M | +173% |
| Equity | DKK 4,1M | +60% |
| Employees | — | — |
Legal name
Speciallæge Danny Svane ApS
CVR number
34074283
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
1. december 2011
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene.
Company purpose
Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed.
Address
Christiansgade 108
Phone
+4531318600
Email
svane@dadlnet.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -12 | -9 | -10 | -82 | 201 | 373 | 370 | 381 | 434 | 71 | 373 | 606 | -23 | -17 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -12 | -9 | -10 | -82 | 201 | 373 | 370 | 381 | 434 | 71 | 373 | 546 | -23 | -17 |
| Depreciation & amort. | -0 | -0 | -0 | -39 | -135 | -139 | -132 | -136 | -115 | -115 | -115 | -0 | -0 | -0 |
| EBIT | -12 | -9 | -10 | -121 | 66 | 234 | 238 | 245 | 319 | -45 | 258 | 546 | -23 | -17 |
| Net financials | 205 | 225 | 169 | 211 | 550 | 694 | 436 | 548 | 1.293 | -170 | 2.839 | -326 | 89 | 1.719 |
| Profit before tax | 193 | 216 | 160 | 90 | 616 | 928 | 674 | 793 | 1.611 | -215 | 3.097 | 220 | 66 | 1.702 |
| Tax | 0 | -3 | -2 | -55 | -12 | 33 | 27 | 48 | 67 | -27 | 143 | 55 | 1 | 42 |
| Net profit | 192 | 218 | 162 | 145 | 628 | 895 | 648 | 746 | 1.545 | -188 | 2.954 | 165 | 65 | 1.661 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 363 | 417 | 398 | 6.664 | 7.452 | 8.991 | 6.963 | 7.042 | 9.549 | 6.966 | 10.399 | 6.030 | 2.578 | 7.026 |
| Equity | 272 | 311 | 374 | 420 | 1.048 | 1.839 | 2.381 | 3.019 | 4.243 | 3.225 | 5.949 | 5.996 | 2.561 | 4.086 |
| Long-term debt | 0 | 0 | 0 | 2.914 | 2.598 | 3.868 | 3.858 | 3.695 | 3.552 | 3.353 | 2.702 | 0 | 0 | 0 |
| Short-term debt | 91 | 106 | 23 | 3.331 | 3.806 | 3.279 | 715 | 329 | 1.753 | 388 | 1.747 | 34 | 17 | 2.940 |
| Total debt | 91 | 106 | 23 | 6.245 | 6.404 | 7.147 | 4.573 | 4.024 | 5.306 | 3.741 | 4.450 | 34 | 17 | 2.940 |
EBITDA margin
-1709500.0%
This company
15.8%
Market median
-10819720% vs market
20122025
Equity ratio
58.2%
This company
38.2%
Market median
+52% vs market
20122025
Return on equity
40.6%
This company
18.4%
Market median
+121% vs market
20122025
Net profit margin
166057600.0%
This company
8.1%
Market median
+2050093727% vs market
20122025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20122025
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-12-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PA Management | Management | 2011 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Speciallæge Danny Svane ApS 
SPECIALLÆGESELSKABET DANNY SVANE ApSBoard members of Speciallæge Danny Svane ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Andreas Stakemann | Management | 0 companies |